Jafron Biomedical Co.,Ltd. (300529.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.19B |
| Enterprise Value | 13.9B |
| P/E Ratio | 23.42 |
| PEG Ratio | -1.21 |
| Price/Sales Ratio | 6.59 |
| Price/Book Ratio | 3.59 |
| Enterprise/Revenue | 6.37 |
| Enterprise/EBITDA | 15.29 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.27 |
| Operating Margin | 0.35 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.15 |
Income Statement
| Revenue | 2.01B |
| Revenue/Share | 2.43 |
| Gross Profit | 1.57B |
| EBITDA | 825.76M |
| Net Income | 532.82M |
| Diluted EPS | 0.69 |
Balance Sheet
| Total Cash | 2.38B |
| Total Cash/Share | 3.03 |
| Total Debt | 175.88M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 2.11 |
| Book Value Per Share | 4.39 |
Price History
| 52-Week Change | -33.56 |
| 52-Week High | 24.66 |
| 52-Week Low | 14.73 |
| Moving Average 50 Days | 16.66 |
| Moving Average 200 Days | 18.62 |
Statistics
| Average Volume | 8.15M |
| Shares Outstanding | 798.61M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.52 |
| Trailing Annual Dividend Yield | 3.3 |
| Payout Ratio | 0.81 |
| Last Split Factor | 19:10 |
| Last Split Date | May 20, 2020 |
AD
